Compounds > buserelin
Page last updated: 2024-08-23

buserelin and Hot Flashes

buserelin has been researched along with Hot Flashes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cury, FL; David, M; Duclos, M; Faria, SL; Freeman, CR; Gagnon, B; Rajan, R; Shenouda, G; Souhami, L; Tanguay, S1
Petas, A; Pettersson, B; Sandow, J; Varenhorst, E1
Kikuchi, I; Kobori, H; Mitsuhashi, N; Sato, Y; Takeuchi, H1

Trials

3 trial(s) available for buserelin and Hot Flashes

ArticleYear
Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer.
    International journal of radiation oncology, biology, physics, 2006, Mar-01, Volume: 64, Issue:3

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Buserelin; Drug Resistance, Neoplasm; Hot Flashes; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Reference Values; Testosterone

2006
Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.
    European urology, 2006, Volume: 50, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Combined Modality Therapy; Drug Administration Routes; Drug Implants; Erectile Dysfunction; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Libido; Male; Middle Aged; Neoadjuvant Therapy; Prostate; Prostatic Neoplasms; Sexual Behavior; Testosterone; Time Factors

2006
A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
    The journal of obstetrics and gynaecology research, 2000, Volume: 26, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leiomyoma; Leuprolide; Luteinizing Hormone; Male; Middle Aged; Ovarian Diseases; Prospective Studies; Treatment Outcome; Ultrasonography; Uterine Diseases; Uterine Hemorrhage

2000